The approval makes ILM-Blue the first DORC posterior dye product available in China, according to a press release from Zeiss.

DORC’s ILM-Blue receives China NMPA approval; expanding global reach to prove high-quality and effective solutions to ophthalmic community: Jena, Germany Saturday, March 29, 202 ...

JENA, Germany, March 27, 2025 /PRNewswire/ -- ZEISS Medical Technology announced today that the ILM staining dye ILM-Blue ® from DORC (Dutch Ophthalmic Research Center (International) B.V.) has ...

To date, ILM-Blue ® remains the only ILM staining solution approved by the FDA. It is marketed under the brand name ...

JENA, Germany, March 27, 2025 /PRNewswire/ -- ZEISS Medical Technology announced today that the ILM staining dye ILM-Blue ® from DORC (Dutch Ophthalmic Research Center (International) B.V.) has ...

JENA, Germany, March 27, 2025 /CNW/ -- ZEISS Medical Technology announced today that the ILM staining dye ILM-Blue ® from DORC (Dutch Ophthalmic Research Center (International) B.V.) has received ...